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Cd (Cd)  is a nephrotoxic  environmental  pollutant  that  causes  generalized  proximal  tubule  dysfunction.
Even  though  the speciﬁc  mechanisms  by  which  Cd damages  the  kidney  have  yet to  be  fully elucidated,
there  is evidence  to suggest  that  some  of  these  nephrotoxic  effects  may  result  from  the ability  of  Cd  to
alter  the  levels  and function  of  metals  such  as  Cu, Se,  Zn  and  Fe  within  the kidney.  In order  to further
explore  this  issue,  we  examined  the  effects  of  subchronic  Cd  exposure  on tissue  levels  of a  panel  of  metals
(Ca, Cu,  Fe,  K, Mg,  Na,  Se  and  Zn)  in  the  rat renal  cortex.  Adult  male  Sprague-Dawley  rats  were  treated
with  CdCl2 (0.6  mg  Cd/kg  body  weight  in  isotonic  saline  by  subcutaneous  injection,  5 days  per  week  for
6,  9  or  12 weeks).  At each  time  point,  24 h  urine  samples  were  collected  and  assayed  for  levels  of  protein,
creatinine,  2 microglobulin  and  cystatin  C.  Samples  of renal  cortex  were  removed  and  assayed  for  levels
of  the  metals  of  interest  by  inductively-coupled  mass  spectrometry  at  Michigan  State  University.  Results
showed  that at  9 and  12 weeks,  Cd  caused  signiﬁcant  increases  in  urine  volume  and  urinary  protein  with
no change  in  creatinine  excretion.  Increases  in  the  excretion  of  the  urinary  biomarkers  2 microglobulin
and  cystatin  C  were  evident  after  6 weeks  of  Cd  exposure.  Results  of the  metal  analyses  showed  that  Cd
caused  signiﬁcant  increases  in  tissue  levels  of Cu  and  Se  at all of  the  time  points  examined.  Tissue levels
of  Zn  were  transiently  elevated  at  6  weeks  but  declined  to control  levels  at  9  and 12 weeks.  Cd caused  a
signiﬁcant  decrease  in  levels  of  Fe  at 9  and  12 weeks.  Cd had  no  effects  on  any  of  the  other  metals.  Tissue
levels  of Cd were  530 ±  52, 863  ±  23, 837  ±  23  ppm  dry  weight  at 6, 9  and  12  weeks,  respectively.  These
results  indicate  that the  early  stages  of  Cd  nephrotoxicity  are  associated  with  alterations  in renal  tissue
levels  of Cu,  Se,  Zn  and  Fe. The  fact  that  the  changes  in  levels  of  the metals  occurred  during  the  early
stages  of  Cd  toxicity  raises  the  possibility  that  the alterations  in  renal  cortical  metal  content  may  play
ysiolo
s).  Pusome  role  in  the  pathoph
©  2016  The  Author(
. Introduction
Cadmium (Cd) is an important nephrotoxic metal that currently
anks 7th on the United States Environmental Protection Agen-
ies Priority List of Hazardous Substances [2]. With the chronic,
ow-level patterns of Cd exposure that are common in humans,
he kidney is the primary target of toxicity. Cd accumulates in the
pithelial cells of the proximal tubule, where it causes a generalized
eabsorptive dysfunction characterized by polyuria and protein-
ria (for reviews see [18,19,36]. These nephrotoxic effects occur
hen circulating Cd that is bound to low molecular proteins orhiol compounds is ﬁltered at the glomerulus and/or presented to
he basolateral cell surface and then taken up by the epithelial cells
f the proximal tubule (for reviews see [36,63,64]. Over time, Cd
∗ Corresponding author.
E-mail address: wprozi@midwestern.edu (W.C. Prozialeck).
ttp://dx.doi.org/10.1016/j.toxrep.2016.09.005
214-7500/© 2016 The Author(s). Published by Elsevier Ireland Ltd. This is an open acces
c-nd/4.0/).gy  or Cd-induced  injury.
blished  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the  CC
BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
accumulates in the cells to reach levels of 150–200 g/g wet  weight
(equivalent to 450–600 g/g dry weight) that cause toxic injury
[18,23,43,44].
While these general effects of Cd on the kidney have been well-
characterized, the speciﬁc molecular mechanisms through which
Cd produces these effects have yet to be fully elucidated. Studies to
address this issue have shown that Cd can produce a myriad of bio-
chemical effects in proximal tubule cells including, the induction
of oxidative stress, reorganization of the cytoskeleton, disruption
of cadherin-mediated homotypic cell adhesion, and activation or
inhibition of various cellular signaling cascades (for reviews see
[13,14,21,27,45,51]. However, in most cases the speciﬁc relation-
ships between these various biochemical effects and the overt
cytotoxic effects of Cd remain unclear.
One of the more widely accepted general mechanisms by which
Cd can affect cell function involves disruption of the actions or
alterations of the physiologic disposition of essential metals. These
essential metals include agents such as Cu, Zn, Se, Fe and Mg,  which
s article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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erve many important physiologic functions. As a stable divalent
ation, Cd is able to interact with many of the same molecular tar-
ets on which these essential metals act. In addition, Cd can interact
ith transport proteins and ion channels that regulate the physio-
ogic disposition of these metals. In a number of important reviews
ver the past 2 decades, various authors have highlighted the fact
hat alterations in the homeostasis or transport of essential metals
ay  play a major role in the pathophysiology of Cd-induced kidney
njury [4,15,31,52,57,58,61]. However, the relationships between
lterations in the homeostasis of individual metals and speciﬁc
ephrotoxic actions of Cd remain unclear.
Over the past 10–15 years, we have been engaged in stud-
es to elucidate mechanisms underlying Cd-induced kidney injury
nd to identify more sensitive biomarkers of Cd nephrotoxicity
40,39,41,36,42]. Most of our in vivo studies have involved the use
f a sub-chronic model of Cd exposure in the rat. This dosing reg-
men, which involves the daily, subcutaneous administration of
dCl2, at a daily dose of 0.6 mg/kg, 5 days per week for up to 12
eeks, has been extensively used by other investigators and is an
ccepted model in the Cd research ﬁeld [1,8,22,40,41,46,48,50]. In
ddition, previous studies from our laboratory have shown that
his treatment protocol can be used to reproducibly induce the
arly stages of Cd nephrotixicty [41,38,42]. In the present study, we
ave analyzed the levels of a panel of essential metals in archived,
rozen tissue samples from our recent Cd biomarker studies [42].
n addition, we consider the results of the metal analyses in rela-
ionship to the severity of Cd-induced kidney injury, as assessed by
istopathology and alterations in speciﬁc urinary biomarkers. The
esults indicate that the early stages of Cd nephrotoxicity are asso-
iated with changes in the tissue levels of several essential metals,
articularly Cu, Se, Zn and Fe.
. Materials and methods
The samples of kidney tissue that were used in the present stud-
es were harvested from rats that had been treated with Cd in a
eries of urinary biomarker studies that were conducted between
012 and the end of 2015. Results of the biomarker studies have
een published recently [42]. These animal studies were conducted
n compliance with the United States NIH Guide for the Care and Use
f Laboratory Animals [32], and they were approved by the Institu-
ional Animal Care and Use Committee of Midwestern University.
dult male Sprague-Dawley rats weighing 250–300 g (Harlan, Indi-
napolis, IN) were housed socially (two rats per plastic cage) on a
2 h light cycle/12 h dark cycle. Animals in the Cd treatment groups
n = 6 for each time point) received daily (Monday-Friday) subcu-
aneous injections of CdCl2 at a dose of 0.6 mg  Cd (5.36 mol) in
.24–0.35 ml  isotonic saline for up to 12 weeks. Control group ani-
als (n = 6 for each time point) received daily injections of the
aline vehicle alone. After 6, 9 and 12 weeks of treatment, animals
ere placed in individual metabolic cages and 24 h urine samples
ere collected. The animals were allowed free access to water at
ll times. Food was also available ad libitum, except during the
eriod in which the urine samples were being collected. The 12
eek Cd treatment protocol was repeated at least twice and data
rom the multiple treatment protocols were pooled whenever pos-
ible. Before the start of each experiment, the Cd concentrations of
he stock solutions used for the various treatment protocols were
eriﬁed by Chemical Solutions, Ltd. (Harrisburg, PA) using the tech-
ique of inductively coupled plasma mass spectroscopy..1. Urine and blood analysis
After collection, the 24 h urine samples were aliquoted into
.5–1.0 ml  portions. The aliquots were frozen at −80 ◦C and later Reports 3 (2016) 740–746 741
assayed for protein, creatinine, cystatin C and 2 microglobulin
as described previously [42]. Blood samples were obtained at the
time the animals were euthanized, and serum levels of cystatin C
were determined by an enzyme-linked immunoabsorbent assay as
described by Prozialeck et al. [42].
2.2. Metal analyses
As noted previously, the tissue samples that were analyzed in
the present study were generated from animal treatment protocols
that were carried out in our laboratories between 2012 and 2015.
At the time the animals were euthanized, samples of renal cortex
(∼50–100 mg  each) were harvested and frozen at −80 ◦C until they
were analyzed for metal content, which was within 6 months after
the end of the treatment period. For the metal analyses, the samples
were shipped on dry-ice to the Diagnostic Center for Population and
Animal Health, at Michigan State University (East Lansing, MI). The
tissues were dried overnight at 75 ◦C and then digested in approxi-
mately 10× the dry tissue mass of nitric acid. The digested samples
were diluted with water to 100× the dried tissue mass. Elemen-
tal analyses were conducted according to the method of Wahlen
et al. [59] using an Agilent 7500ce Inductively Coupled Plasma –
Mass Spectrometer (ICP/MS) (Aligent Technologies, Inc.) Brieﬂy, the
tissue digests and standards were diluted 20-fold with a solution
containing 0.5% EDTA and Triton X-100, 1% ammonium hydrox-
ide, 2% propanol and 20 ppb of scandium, rhodium, indium and
bismuth as internal standards. The ICP/MS was  tuned to yield a
minimum of 7500 cps sensitivity for 1 ppb yttrium (mass 89), less
than 1.0% oxide level as determined by 156/140 mass ratio and less
than 2.0% double charged ions as determined by the 70/140 mass
ratio. Elemental concentrations were calibrated using a 4-point lin-
ear curve of the analyte-internal standard response ratio. Standards
were from GFS Chemicals (Powell, OH). Results were expressed as
g metal/g dry tissue weight. This was done to avoid any variability
that might be caused by the presence of frost or water condensation
on the tissue samples. The concentration of the metals based on the
wet weight of the tissue samples can be estimated by multiplying
the concentration/per unit of dry weight by a factor of 0.33.
2.3. Histopathologic analyses
Transverse slices of renal cortical tissue (∼5 mm thick) were
placed in 4% formalin and sent for analysis to Colorado Histo-
Prep Services (Ft. Collins, CO), where the samples were embedded
in parafﬁn, sectioned at a thickness of 4  and stained with
hematoxylin and eosin. The samples were viewed and histologic
changes were semi-quantitatively evaluated by a trained veteri-
nary histopathologist. The slides were evaluated for inﬂammation,
necrosis, and apoptosis of the proximal tubules, as well as any other
lesions that might have been present. Histopathologic changes
were rated on a 6 point scale as follows: 0 = No appreciable changes,
1 = Minimal (individually scattered changes), 2 = Mild (changes in
less than 10% of tubules), 3 = Moderate (changes in 10–25% of
tubules), 4 = Moderately Severe (changes in 25–50% of tubules),
5 = Severe (changes in more than 50% of tubules).
Photographic images of representative tissue sections were
obtained in our laboratory using a Nikon Eclipse E-400 microscope
equipped with a 20× objective lens. Images were captured with
a digital camera (Media Cybernetics), using automated exposure
times and gain settings, and then processed using Adobe Photoshop
(Version CS6) to enhance brightness and contrast. Identical adjust-
ments were made in all images from the control and the Cd-treated
samples.
742 W.C. Prozialeck et al. / Toxicology Reports 3 (2016) 740–746
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Table 1
Lack of effect of Cd on levels of Mg,  Ca, Na and K in renal cortex.
Treatment Metal
Mg Ca Na K
Control 6 Weeks 705 ± 4.04 227 ± 8.9 4138 ± 588 11,876 ± 441
Cd 6 weeks 655 ± 8.2 241 ± 13.3 4450 ± 524 11,216 ± 166
Control 9 Weeks 759 ± 3.9 272 ± 1.9 4227 ± 533 12,165 ± 414
Cd 9 weeks 724 ± 27 253 ± 18.5 3786 ± 231 12,764 ± 546
Control 12 Weeks 751 ± 9.9 304 ± 15.8 3883 ± 137 12,694 ± 234Fig. 1. Effects of Cd on renal co
.4. Statistical analysis
Statistical analyses were done using the GraphPad Prism Com-
uter Program. Data for the various urinary parameters, which
howed heterogeneity of variances, were evaluated by the non-
arametric Kruskal-Wallis test and Dunn’s post hoc test, as
escribed by Prozialeck et al. [41]. Data for the tissue metal levels,
hich showed homogeneity of variances, were analyzed by ANOVA
nd Tukey’s post-hoc test.
. Results
The graphs in Fig. 1 show the changes in levels of the metals
hat were signiﬁcantly altered by Cd exposure. Several key ﬁndings
re immediately apparent. First, Cd differentially affected the tis-
ue levels of the various metals. In some cases, these effects were
elatively straightforward, but in other cases, they were more com-
lex and variable. For example, Cd caused a signiﬁcant (2–3 fold)
ncrease in levels of Cu that were evident as early as 6 weeks and
hen persisted at this same level throughout the 12 week treat-
ent period. Cd treatment also increased tissue levels of Se. It is
oteworthy that the levels of Se in the control animals tended to
ncrease throughout the treatment period. At the same time, the
evel of Se in the samples from the Cd-treated animals were consis-
ently (about 25–30%) higher than in the time-matched controls.
y contrast, Cd decreased renal cortical levels of Fe to about 50% of
ontrol values, an effect that was statistically signiﬁcant at 9 andCd 12 weeks 754 ± 15.5 320 ± 9.6 4575 ± 310 14,271 ± 426
12 weeks. Cd appeared to have biphasic, time-dependent effects
on renal cortical levels of Zn. After 6 weeks of Cd treatment, tis-
sue levels of Zn were signiﬁcantly elevated to about 140% control
values. However, by 9 weeks, Zn levels fell back to control levels
and by 12 weeks, they appeared to be slightly below control levels,
although the difference was  not statistically signiﬁcant. Cd had no
overall effect on tissue levels of several other key metals including
Ca, Mg,  K and Na (Table 1).
In evaluating the results of the metal analyses, a key factor that
needs to be considered is the level of kidney injury during the time
frame in which the early Cd-induced changes in renal cortical metal
content are occurring. This Cd dose and treatment protocol have
been shown to trigger the early stages of Cd-induced kidney injury
[38,39,37]. Results of the biomarker studies from which the present
tissue samples were obtained showed that after 9 weeks of expo-
W.C. Prozialeck et al. / Toxicology Reports 3 (2016) 740–746 743
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ure, Cd increased urine volume and total urinary protein excretion
ut had no signiﬁcant effect on the urinary excretion of creatinine
ven after 12 weeks. The development of polyuria and proteinuria,
ith no change in creatinine is characteristic of Cd-induced proxi-
al  tubule dysfunction [41,36]. With regard to the present studies,
t is noteworthy that urinary levels of the biomarkers cystatin C and
2 microglobulin in the samples from the Cd-treated animals were
igniﬁcantly elevated after only 6 weeks of Cd exposure, and then
ontinued to increase throughout the remainder of the 12 week
d treatment period. These results are similar to those in previous
eports [41,39,36,35,42] and they indicate that between 9 and 12
eeks, this dose of Cd induces a mild to moderate level of proximal
ubule dysfunction (polyuria and proteinuria). However, more sub-
le changes in proximal tubule dysfunction can be detected about
 weeks earlier as evidenced by increases in the urinary excretion
f biomarkers such as cystatin C and 2 microglobulin. Additional
tudies in which we utilized this same treatment protocol showed
hat Cd had no effect on serum levels of either creatinine [41,39]
r cystatin C [42], indicating that Cd had no effect on glomeru-
ar function and that the proximal tubule is the primary target of
ephrotoxic injury.
To further evaluate the severity of Cd-induced kidney injury, a
eries of histopathologic analyses of hematoxylin and eosin stained
issue sections were conducted. The ﬁrst analysis involved the qual-
tative evaluation of the tissue sections in our laboratory. Fig. 2
hows typical images of tissue sections of outer renal cortex from
ontrol and Cd-treated animals. Note that proximal tubule epithe-
ial cells in control samples (top left) exhibited cuboidal shapes,
ell-deﬁned nuclei, and a uniform cytoplasm, with no spaces or
aps between the cells. By contrast, the epithelial cells in sam-
les from Cd-treated animals (top right and bottom row) showed
n irregular appearance, with gaps between cells (long arrows).orphology of the renal cortex.
However, the cells remained attached to the basement membrane
and showed little overt evidence of necrosis. In addition, the sam-
ples from the 12 week Cd treatment group showed some areas
of enhanced eosinophilic staining in the proximal tubules (short
arrows in bottom right image). Analyses of the glomeruli and distal
segments of the nephron revealed no evidence of pathology.
For the second phase of the histopathologic analyses, hema-
toxylin and eosin-stained tissue sections were evaluated semi-
quantitatively by a trained pathologist at Colorado Histo-Prep
Services. Results of these histopathologic analyses are summarized
in Fig. 3. As may  be seen from the graphs, Cd had only modest
effects on over-all proximal tubule morphology. The most consis-
tent change was  a slight increase in the number of apoptotic cells
in the proximal tubule that only reached statistical signiﬁcance at
12 weeks. Cd had no signiﬁcant effect on the evaluation scores
for necrosis or inﬂammation. In addition, the total histopatho-
logic scores (calculated by adding scores for apoptosis, necrosis and
inﬂammation) were not altered by Cd. This ﬁnding is consistent
with previous studies showing that this Cd dosing regimen causes
apoptosis in a low, but consistent percentage (2.0–5%) of proximal
tubule cells [38], while producing little evidence of general inﬂam-
mation or necrosis. Together, the biomarker studies summarized in
Prozialeck et al. [42] and the morphologic analyses in Figs. 2 and 3
indicate that even after 12 weeks, using this treatment protocol,
the level of Cd-induced kidney injury is relatively mild.
4. DiscussionThe results of the present studies show that after subchronic
administration of a modest dose (0.6 mg/kg SC, 5 days per week
for 6–12 weeks), Cd causes signiﬁcant changes in the renal cortical
levels of several key metals, particularly Cu, Se, Fe and Zn. It should
744 W.C. Prozialeck et al. / Toxicology
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in the workplace and through the environment (for reviews seeig. 3. Summary of effects of Cd on Histopathological changes in the proximal
ubule.
e noted that even though many previous studies have shown that
d can alter renal levels of these metals [11,26,55,53], there are
everal aspects of the present studies that are unique and merit
pecial attention.
First, the present studies involved the use of speciﬁc Cd dosing
nd treatment protocols that have been widely used by numerous
nvestigators to characterize the toxicokinetics of Cd in the body,
o examine possible mechanisms by which Cd damages the kidney,
nd to validate the use of various biomarkers of Cd-induced kidney
njury [1,8,22,40,41,39,38,46,48,50]. However, there is almost no
nformation in the literature regarding the effects of this speciﬁc
d treatment regimen on levels of other metals in the kidney. Most
f the previous studies to address this issue involved vastly differ-
nt treatment regimens in which relatively high doses of Cd were
iven either orally or intra-peritoneally for relatively short periods
f time, typically less than 5 weeks [9,10,53,55,61]. Since this model
as been so widely used in the Cd ﬁeld, information regarding the
ffects of this particular Cd treatment on the levels of metals in
he kidney may  be especially relevant to previous mechanistic and
iomarker studies.
A second unique aspect of the present work is that the present
etal analyses focused on renal cortical tissue. This is signiﬁcant
ecause the primary target of Cd toxicity is the renal cortex, with
n approximate 4-fold greater concentration of Cd in the cortex
s compared to the medulla [56]. In addition, most of the metals
xamined in the present study tend to concentrate in the prox-
mal tubules [45]. However, most of the previous studies on the
ffects of Cd on metals in the kidney involved the analyses of whole
idneys or kidney homogenates [53,55,61] an approach that could
bscure possible Cd-induced changes in the metal content of the
enal cortex. The results of the present studies speciﬁcally highlight
he Cd-induced changes in the metal content of the renal cortex.
Probably, the most unique and important aspect of the
resent work is that it includes quantitative histopathologic anal-
ses, along with a discussion of changes in various biomarkers
f Cd-nephrotoxicity. By considering the histopathological and
iomarker ﬁndings, we clearly show that at the time the ini-
ial changes in renal metal content are occurring, the level of
d-induced proximal tubule injury is mild. This suggests that alter-
tions in renal metal content may  represent early events in the
athophysiology of Cd nephrotoxicity. Few, if any of the previous
tudies on the effects of Cd on levels of metals in the kidney included
uch detailed histopathological and biomarker analyses. Reports 3 (2016) 740–746
As a consequence of the differences in the way  various investi-
gators have reported renal levels of these metals (mass vs. molar
units; dry weight vs wet  weight; whole kidney vs renal cortex,
etc.), direct comparisons of results from different laboratories can
be difﬁcult. Nevertheless, after making adjustments for these vari-
ables, the renal cortical levels of the metals that we observed in the
present studies are in ranges reported by other investigators who
examined various types of renal pathology in the rat [24,25,55,61].
Of particular note, the levels of Cd that we found to be associ-
ated with the onset of renal injury are in ranges reported by other
investigators [17,18,20,26,43,23].
In addition, the Cd-induced changes in renal metal content that
we observed are qualitatively similar to various results reported in
the literature. For example, Lee et al. [26] showed that Cd given via
subcutaneous injection to female rats for 5 days caused signiﬁcant
increases in renal levels of Cu and Zn. In another study in which
Cd was  given to pregnant rats via the drinking water, Turgut et al.
[55] found that Cd increased renal levels of Zn and reduced Fe lev-
els. In addition, Toman et al. [53] reported that Cd increased renal
levels of Se. On the other hand, Erdem et al. [11] reported that Cd
administered via drinking water to male rats actually decreased
kidney levels of Cu and Zn. It should be noted that the levels of
metals reported in the latter study were several orders of magni-
tude lower than in the other cited studies. While we cannot explain
these apparent discrepancies, they may be related to differences in
the routes of Cd administration, strain and gender differences, tis-
sue collection procedures, analytical methods and/or methods for
the expression of results that were used in the various studies.
An important question, of course, is what are the mechanisms
by which Cd alters renal cortical metal content? From a concep-
tual perspective, it would seem that there are only a few general
mechanisms through which Cd could alter the renal cortical con-
centrations of the various metals. For those metals that showed
increased levels, (Cu and Se), Cd could be either enhancing the
cellular uptake of the metals and/or inducing the synthesis of pro-
teins that bind/store the metals within the cells. For a metal such
as Fe, which decreases in concentration with Cd exposure, Cd could
be either inhibiting the cellular uptake and/or inducing the bind-
ing/storage of Fe within the cells of the proximal tubule. For a metal
such as Zn, which shows biphasic effects, Cd could be exerting mul-
tiple, time-dependent effects on uptake and/or storage. There is
evidence in the literature to support many of these possibilities.
For example, it has long been recognized that Cd can inﬂuence tis-
sue levels of Fe and vice versa (for review see [52]. In general, Cd
interferes with the absorption and storage of Fe and low levels of Fe
can lead to increased Cd accumulation in tissues such as the kidney
[52]. Likewise, the association between Cd exposure and increases
in renal levels of Zn have long been recognized. Nordberg and
coworkers examined the effects of Cd on levels of Zn in horse kidney
[23,33]. As renal levels of Cd increased, there was a steady increase
in levels of Zn. The authors attributed this effect to the induction
of metallothionein in the proximal tubule, which acts to sequester
both Cd and Zn. It is noteworthy that with longer term exposure, the
ratio of Zn/Cd bound to metallothionein actually decreased. Such
effects could account for the biphasic effect (increase followed by
decrease) that we observed in our rat model. For additional infor-
mation regarding the possible mechanisms through which Cd can
affect the homeostasis of various metals, the reader is referred to
an outstanding review by Moulis [31].
One ﬁnal point to consider is that the present ﬁndings could also
have important implications regarding exposures to mixtures of
metals. Simultaneous exposure to multiple metals is common, both[5–7,29,34,47,54]. Despite overwhelming evidence that humans
can be exposed to multiple metals, there are relatively few experi-
mental studies examining the potential synergistic or antagonistic
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ffects of exposure to multiple types of metals. Most of these studies
how increased kidney dysfunction and necrosis of tubular epithe-
ial cells with exposure to Cd in combination with other metals
6,12,28,62].
Our results show that Cd increases renal cortical levels of Cu
nd Fe under controlled conditions in which the animals were only
xposed to non-toxic levels of Cu and Fe, mainly through their diet.
n intriguing question is how might Cd inﬂuence renal cortical lev-
ls of these metals in subjects exposed to Cd along with toxic levels
f Cu and/or Fe? Our ﬁndings indicate that Cd may  increase the
enal accumulation of Cu, which may  have either adverse or pro-
ective effects in the kidney depending on the level of exposure [10].
n the other hand, it is well known that metals such as Zn and Se
an greatly reduce the nephrotoxic effects of Cd [3,9,16,30,49,60].
o-exposure to Cd and these metals may  actually attenuate the
oxic effects of Cd in the kidney. It remains to be determined how
hese Cd-metal interactions may  relate to mixed metal exposure in
umans.
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